CELEX: 62019TA0696
Language: en
Date: 2020-07-08 00:00:00
Title: Case T-696/19: Judgment of the General Court of 8 July 2020 — Teva Pharmaceutical Industries v EUIPO (Moins de migraine pour vivre mieux) (EU trade mark — Application for EU word mark Moins de migraine pour vivre mieux — Absolute ground for refusal — No distinctive character — Article 7(1)(b) of Regulation (EU) 2017/1001)

12.10.2020   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 339/19
            
         
      Judgment of the General Court of 8 July 2020 — Teva Pharmaceutical Industries v EUIPO (Moins de migraine pour vivre mieux)
      (Case T-696/19) (1)
      
      (EU trade mark - Application for EU word mark Moins de migraine pour vivre mieux - Absolute ground for refusal - No distinctive character - Article 7(1)(b) of Regulation (EU) 2017/1001)
      (2020/C 339/24)
      Language of the case: English
      
         Parties
      
      
         Applicant: Teva Pharmaceutical Industries Ltd (Petah Tikva, Israel) (represented by: J. Bogatz and Y. Stone, lawyers)
      
         Defendant: European Union Intellectual Property Office (represented by: L. Rampini and V. Ruzek, acting as Agents)
      
         Re:
      
      Action brought against the decision of the Fifth Board of Appeal of EUIPO of 12 August 2019 (Case R 778/2019-5), relating to an application for registration of the word sign Moins de migraine pour vivre mieux as an EU trade mark.
      
         Operative part of the judgment
      
      The Court:
      
                  1.
               
               
                  Dismisses the action;
               
            
                  2.
               
               
                  Orders Teva Pharmaceutical Industries Ltd to pay the costs.
               
            
         (1)  OJ C 413, 9.12.2019.